Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1

被引:113
作者
Jourdan, M
De Vos, J
Mechti, N
Klein, B
机构
[1] CHU Montpellier, INSERM, U475, F-34197 Montpellier, France
[2] CHU Montpellier, Unit Cellular Therapy, F-34197 Montpellier, France
关键词
myeloma; IL-6; IGF; apoptosis;
D O I
10.1038/sj.cdd.4400758
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As survival regulation is a key process in multiple myeloma biology, we have studied the Bcl-2 family proteins that can be regulated by three myeloma cell survival factors: interleukin-6 (IL-6), interferon-alpha (IFN-alpha) and insulin-like growth factor (IGF-1). Eleven myeloma cell lines, whose survival and proliferation are dependent on addition of IL-6, variably expressed 10 anti-apoptotic or pro-apoptotic proteins of the Bcl-2-family. When myeloma cells from four cell lines were IL-6 starved and activated with IL-6 or IFN-alpha, we observed that only Mcl-1 expression was up-regulated with myeloma cell survival induction. Nor was obvious regulation of these 10 pro-apoptotic or anti-apoptotic proteins found with IGF-1, another potent myeloma cell survival factor. Our results indicate that the myeloma cell survival activity of IL-6 linked to Bcl-xL regulation cannot be generalized and emphasize that Mcl-1 is the main target of IL-6 and IFN-alpha stimulation. However, other changes in the activity of the Bcl-2 protein family or other apoptosis regulators must be identified to elucidate the IGF-1 action mechanism.
引用
收藏
页码:1244 / 1252
页数:9
相关论文
共 42 条
[1]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]   TYROSINE PHOSPHORYLATION OF JAK-TYK KINASES IN MALIGNANT PLASMA-CELL LINES GROWTH-STIMULATED BY INTERLEUKIN-6 AND INTERLEUKIN-11 [J].
BERGER, LC ;
HAWLEY, TS ;
LUST, JA ;
GOLDMAN, SJ ;
HAWLEY, RG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (01) :596-605
[3]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[4]   JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells [J].
De Vos, J ;
Jourdan, M ;
Tarte, K ;
Jasmin, C ;
Klein, B .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (04) :823-828
[5]   GROWTH KINETICS OF PLASMA-CELL MYELOMA [J].
DREWINKO, B ;
ALEXANIAN, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 58 (05) :1247-1253
[6]  
FERLIN M, 2000, IN PRESS BR J HAEMAT
[7]  
Ferlin-Bezombes M, 1998, J IMMUNOL, V161, P2692
[8]   Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines [J].
GeorgiiHemming, P ;
Wiklund, HJ ;
Ljunggren, O ;
Nilsson, K .
BLOOD, 1996, 88 (06) :2250-2258
[9]  
GREIPP PR, 1988, BLOOD, V72, P219
[10]   BCL-2 family members and the mitochondria in apoptosis [J].
Gross, A ;
McDonnell, JM ;
Korsmeyer, SJ .
GENES & DEVELOPMENT, 1999, 13 (15) :1899-1911